Suita, Japan

Makoto Kondo

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Osaka University. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Makoto Kondo. Retrieved from https://idiyas.com/inventor/makoto-kondo-prq0vko7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Makoto Kondo: Innovator in Pain Treatment

Introduction

Makoto Kondo is a distinguished inventor based in Suita, Japan. He has made significant contributions to the field of pain management through his innovative research and development of pharmaceutical compositions.

Latest Patents

Kondo holds a patent for a method of treating pain with a serotonin-3 receptor agonist. This invention provides a drug for preventing or treating chronic pain, as well as a method for screening compounds that exhibit serotonin-3 receptor agonist activity. The pharmaceutical composition includes a compound that can effectively address both chronic and acute pain.

Career Highlights

Kondo is affiliated with Osaka University, where he conducts his research and development activities. His work has been pivotal in advancing the understanding of pain treatment methodologies.

Collaborations

Kondo has collaborated with notable colleagues, including Shoichi Shimada and Yukiko Yamamoto, to further enhance the impact of his research in the field of pain management.

Conclusion

Makoto Kondo's innovative work in the treatment of pain exemplifies the importance of research in developing effective pharmaceutical solutions. His contributions continue to influence the medical community and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…